Article
Evaluation of MicroRNA-122 as a Biomarker for Chronic Hepatitis C Infection and as a…
Hepatic Medicine: Evidence and Research · 2021 · Elabd NS, Tayel SI, Elhamouly MS, Hassanein SA, Kamaleldeen SM, Ahmed FE, Rizk M, Gadallah AA, Ajlan SE, Sief AS
Key facts
| Title | Evaluation of MicroRNA-122 as a Biomarker for Chronic Hepatitis C Infection and as a Predictor for Treatment Response to Direct-Acting Antivirals |
|---|---|
| First author | Elabd NS, Tayel SI, Elhamouly MS, Hassanein SA, Kamaleldeen SM, Ahmed FE, Rizk M, Gadallah AA, Ajlan SE, Sief AS |
| Journal | Hepatic Medicine: Evidence and Research |
| Published | Mar 15, 2021 |
| DOI | 10.2147/HMER.S292251 |
| Devices mentioned | 090506, K001460, K010550, K020810, K021326, K030328, K030950, K040882, K063243, K071146, K072138, K073091 and 42 more |
| Product codes mentioned | CDP, CEC, CEP, CFT, CGJ, CHP, DAP, DEW, DHX, ITX, IYO, JFT and 33 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1